[HTML][HTML] Quality control in systematic reviews and meta-analyses

MJ Bown, AJ Sutton - European journal of vascular and endovascular …, 2010 - Elsevier
Systematic reviews and meta-analyses are being submitted to, and being published by
biomedical journals with increasing frequency. In order to maintain the utility of such …

[HTML][HTML] Current management of esophageal cancer

XB D'Journo, PA Thomas - Journal of thoracic disease, 2014 - ncbi.nlm.nih.gov
Management of esophageal cancer has evolved since the two last decades.
Esophagectomy remains the primary treatment for early stage esophageal cancer although …

Outcomes of Patients With Esophageal Cancer Staged With [18F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG …

AM Monjazeb, G Riedlinger, M Aklilu… - Journal of clinical …, 2010 - ascopubs.org
Purpose To determine whether [18F] fluorodeoxyglucose positron emission tomography
(FDG-PET) can delineate patients with esophageal cancer who may not benefit from …

Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors

M Yanagawa, M Tatsumi, H Miyata… - Journal of nuclear …, 2012 - Soc Nuclear Med
Recently, PET response criteria in solid tumors (PERCIST) have been proposed as a new
standardized method to assess chemotherapeutic response metabolically and …

Ineffectiveness of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in …

G Piessen, G Petyt, A Duhamel, X Mirabel… - Annals of …, 2013 - journals.lww.com
Objective: To evaluate the role of 18 F-fluorodeoxyglucose-positron emission tomography
(FDG-PET) in the assessment of tumor response after the completion of neoadjuvant …

Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary …

GW Dittrick, JM Weber, R Shridhar, S Hoffe… - Annals of surgical …, 2012 - Springer
Background Neoadjuvant chemoradiation (NCRT) has become the preferred treatment for
patients with locally advanced esophageal cancer. Survival often is correlated to degree of …

PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity

CT Liao, HM Wang, SF Huang, IH Chen… - Journal of Nuclear …, 2011 - Soc Nuclear Med
We prospectively evaluated the sensitivity and specificity of 18F-FDG PET in the detection of
neck lymph node metastases in patients with oral cavity squamous cell carcinoma (OSCC) …

[HTML][HTML] Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer

N Kim, H Cho, M Yun, KR Park, CG Lee - Radiation Oncology, 2019 - Springer
Background To identify whether early metabolic responses as determined using 18 F-
fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) …

[HTML][HTML] Neoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting …

E Bollschweiler, AH Hölscher, M Schmidt… - Chinese Journal of …, 2015 - ncbi.nlm.nih.gov
Patients with advanced esophageal cancer (T3-4, N) have a poor prognosis.
Chemoradiation or chemotherapy before esophagectomy with adequate lymphadenectomy …

Diagnosis and staging of cancer of the esophagus and esophagogastric junction

Z Li, TW Rice - Surgical Clinics of North America, 2012 - Elsevier
Esophageal/esophagogastric junction cancer staging in the 7th edition of the AJCC staging
manual is data driven and harmonized with gastric staging. New definitions are Tis, T4 …